Beyond the cure: the need to implement a long-term follow-up system for childhood cancer survivors in Colombia Natalia Godoy-Casasbuenasa , Óscar Ramírez
DOI:
https://doi.org/10.35509/01239015.750Keywords:
Survivors of childhood cancer; late effects; long-term follow-up; survivalAbstract
With the advent of high-quality, multidisciplinary treatments, the overall 5-year cancer survival in the pediatric population has improved considerably, reaching as much as 80% in high-income countries. In Colombia, there has also been a progressive increase in overall 5-year survival, particularly for hematologic malignancies. Consequently, the number of survivors of childhood cancer has increased significantly in recent years and, together with them, the appearance of late adverse events related to increased morbidity and risk of premature death in adulthood. Although follow-up strategies have been implemented for childhood cancer survivors in high-income countries, few efforts have been made in Colombia to implement these strategies. In fact, the common practice in most treatment centers is to discharge the child who has undergone 5 years of cancer follow-up, without precise instructions for long-term follow-up. The objective of this paper is to argue about the need to design and implement follow-up strategies for survivors of childhood cancer in the Colombian context.
Author Biography
Oscar Ramírez Wurttemberger, Sistema de Vigilancia del cáncer pediátrico (VIGICANCER), Fundación POHEMA de Cali, Colombia
Registro Poblacional de Cáncer de Cali, Universidad del Valle, Cali, Colombia
Centro Médico Imbanaco de Cali, Colombia
References
Marina N. Long-term survivors of childhood cancer. The medical consequences of cure. Pediatr Clin North Am. 1997;44(4):1021-42. https://doi.org/10.1016/s0031-3955(05)70543-5
Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer. 2009;45(6):992-1005. https://doi.org/10.1016/j.ejca.2008.11.042
Winther JF, Kenborg L, Byrne J, Hjorth L, Kaatsch P, Kremer LC, et al. Childhood cancer survivor cohorts in Europe. Acta Oncol. 2015;54(5):655-68. https://doi.org/10.3109/0284186X.2015.1008648
Hewitt M, Weiner S, Simone J. Childhood cancer survivorship: improving care and quality of life. Council NR, editor: National Academy of Sciences; 2003.
Phillips SM, Padgett LS, Leisenring WM, Stratton KK, Bishop K, Krull KR, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev. 2015;24(4):653-63. https://doi.org/10.1158/1055-9965.EPI-14-1418
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 populationbased registries in 71 countries. Lancet. 2018;391(10125):1023-75. https://doi.org/10.1016/S0140-6736(17)33326-37.
Ramirez O, Aristizabal P, Zaidi A, Ribeiro R, Bravo L. Implementing a childhood cancer outcomes surveillance system within a population-based cancer registry. J Global Oncol. 2018;4:1-11. https://doi.org/10.1200/JGO.17.00193
Piñeros Petersen M. El abandono del tratamiento en los niños con cáncer: un reto para todos. Rev Colomb Cancerol. 2011;15(1):3-4
Ramirez O, Aristizabal P, Zaidi A, Gagnepain-Lacheteau A, Ribeiro RC, Bravo LE. Childhood cancer survival disparities in a universalized health system in Cali, Colombia. Pediatric Hematology Oncology Journal. 2018;3(4):79-87.
Oeffinger KC, Nathan PC, Kremer LC. Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Hematol Oncol Clin North Am. 2010;24(1):129-49. https://doi.org/10.1016/j.hoc.2009.11.013
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572-82. https://doi.org/10.1056/NEJMsa060185
Schwartz CL. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist. 1999;4(1):45-54.
Skinner R, Wallace WH, Levitt GA, Group UCsCSGLE. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol. 2006;7(6):489-98. https://doi.org/10.1016/S1470-2045(06)70724-0
Institute of Medicine, National Research Council. From Cancer Patient to Cancer Survivor: Lost in Transition. Hewitt M, Greenfield S, Stovall E, editors. Washington, DC: The National Academies Press; 2006. 534 p.
Goldsby RE, Ablin AR. Surviving childhood cancer; now what? controversies regarding long-term follow-up. Pediatr Blood Cancer. 2004;43(3):211-4. https://doi.org/10.1002/pbc.20091
Murcia E, Aguilera J, Wiesner C, Pardo C. Oncology services supply in Colombia. Colomb Med (Cali). 2018;49(1):89-96. https://doi.org/10.25100/cm.v49i1.3620
González-Mariño MA. Evaluation of the need for specialists in oncology, Bogota, Colombia, 2015. Rev Salud Publica (Bogota). 2018;20(1):27-33. https://doi.org/10.15446/rsap.V20n1.60290
Congreso de Colombia. Ley 1388 del 26 de Mayo de 2010 “Por el derecho a la vida de los niños con cáncer en Colombia”. Bogotá, 2010.
Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmonary outcomes in survivors of childhood cancer: a systematic review. Chest. 2011;140(4):881-901. https://doi.org/10.1378/chest.10-2133
Hudson M, Mertens A, Yasui Y, Hobbie W, Chen H, Gurney J, et al. Health Status of Adult Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Journal of the American Medical Association , 2003 Sep 25;290(12):1583-92. https://doi.org/10.1001/jama.290.12.1583
Oancea SC, Brinkman TM, Ness KK, Krull KR, Smith WA, Srivastava DK, et al. Emotional distress among adult survivors of childhood cancer. J Cancer Surviv. 2014;8(2):293-303. https://doi.org/10.1007/s11764-013-0336-0
Smith WA, Li C, Nottage KA, Mulrooney DA, Armstrong GT, Lanctot JQ, et al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer. 2014;120(17):2742-50. https://doi.org/10.1002/cncr.28670
Hodgson DC, Hudson MM, Constine LS. Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity. Semin Radiat Oncol. 2007;17(3):230-42. https://doi.org/10.1016/j.semradonc.2007.02.009
Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 2012;104(18):1386-95. https://doi.org/10.1093/jnci/djs344
Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730-41. https://doi.org/10.1056/NEJMoa0900386
Barlogis V, Auquier P, Bertrand Y, Chastagner P, Plantaz D, Poiree M, et al. Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program. Haematologica. 100. Italy2015. p. e186-9. https://doi.org/10.3324/haematol.2014.116574
Pekacka A. The Role of Intraarterial Chemotherapy in the Management of Retinoblastoma. Journal of ophthalmology. 2020;2020:3638410-. https://doi.org/10.1155/2020/3638410
He X, Gao Z, Xu H, Zhang Z, Fu P. A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes. J Orthop Surg Res. 2017;12(1):5. https://doi.org/10.1186/s13018-016-0500-0
Wakefield CE, McLoone J, Goodenough B, Lenthen K, Cairns DR, Cohn RJ. The psychosocial impact of completing childhood cancer treatment: a systematic review of the literature. J Pediatr Psychol. 2010;35(3):262-74. https://doi.org/10.1093/jpepsy/jsp056
Abrams AN, Hazen EP, Penson RT. Psychosocial issues in adolescents with cancer. Cancer Treat Rev. 2007;33(7):622-30. https://doi.org/10.1016/j.ctrv.2006.12.006
D’Agostino NM, Edelstein K. Psychosocial challenges and resource needs of young adult cancer survivors: implications for program development. J Psychosoc Oncol. 2013;31(6):585-600. https://doi.org/10.1080/07347332.2013.835018
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. https://doi.org/10.1001/archpsyc.62.6.593
Brinkman TM, Li C, Vannatta K, Marchak JG, Lai JS, Prasad PK, et al. Behavioral, Social, and Emotional Symptom Comorbidities and Profiles in Adolescent Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2016;34(28):3417-25. https://doi.org/10.1200/JCO.2016.66.4789
Winther J, Kenborg L, Byrne J, al e. Childhood cancer survivor cohorts in Europe. Acta Oncologica. 2015; 54(5):655-68. https://doi.org/10.3109/0284186X.2015.1008648
Parikh NS, Howard SC, Chantada G, Israels T, Khattab M, Alcasabas P, et al. SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings. Pediatr Blood Cancer. 2015;62(8):1305-16. https://doi.org/10.1002/pbc.25501
Signorelli C, Wakefield CE, Fardell JE, Wallace WHB, Robertson EG, McLoone JK, et al. The impact of long-term follow-up care for childhood cancer survivors: A systematic review. Crit Rev Oncol Hematol. 2017;114:131-8. https://doi.org/10.1016/j.critrevonc.2017.04.007
Oeffinger K, CNathan P, Kremer LCM. Challenges After Curative Treatment for Childhood Cancer and Long-Term Follow up of Survivors. Pediatr Clin N Am. 2008;55:251–73. https://doi.org/10.1016/j.pcl.2007.10.009
Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group Long-Term Follow-Up Guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22(24):4979-90. https://doi.org/10.1200/JCO.2004.11.032
Wallace WH, Thompson L, Anderson RA. Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance. Bmj. 2013;346:f1190. https://doi.org/10.1136/bmj.f1190
Skinner R, Wallace WH, Levitt GA. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol. 2006;7(6):489-98. https://doi.org/10.1016/S1470-2045(06)70724-0
Dutch Childhood Oncology Group. Guidelines for follow-up in survivors of childhood cancer 5 years after diagnosis 2010 [Available from: https://www.skion.nl/workspace/uploads/vertaling-richtlijn-LATER-versie-final-okt-2014_2.pdf.
Landier W, Skinner R, Wallace WH, Hjorth L, Mulder RL, Wong FL, et al. Surveillance for Late Effects in Childhood Cancer Survivors. J Clin Oncol. 2018;36(21):2216-22. https://doi.org/10.1200/JCO.2017.77.0180
Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16(3):e123-36. https://doi.org/10.1016/S1470-2045(14)70409-7
Mulder RL, Kremer LC, Hudson MM, Bhatia S, Landier W, Levitt G, et al. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2013;14(13):e621-9. https://doi.org/10.1016/S1470-2045(13)70303-6
Dorp Wv, Mulder RL, Kremer LCM, Hudson MM, Heuvel-Eibrink MMvd, Berg MHvd, et al. Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium. Journal of Clinical Oncology. 2016;34(28):3440-50. https://doi.org/10.1200/JCO.2015.64.3288
Skinner R, Mulder RL, Kremer LC, Hudson MM, Constine LS, Bardi E, et al. Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Lancet Oncol. 2017;18(2):e75-e90. https://doi.org/10.1200/JCO.2015.64.3288
Tonorezos ES, Barnea D, Cohn RJ, Cypriano MS, Fresneau BC, Haupt R, et al. Models of Care for Survivors of Childhood Cancer From Across the Globe: Advancing Survivorship Care in the Next Decade. Journal of Clinical Oncology. 2018;36(21):2223-30. https://doi.org/10.1200/JCO.2017.76.5180
Jacobs LA, Shulman LN. Follow-up care of cancer survivors: challenges and solutions. Lancet Oncol. 2017;18(1):e19-e29. https://doi.org/10.1016/S1470-2045(16)30386-2
Husmann DA. Cancer screening in the pediatric cancer patient: a focus on genitourinary malignancies, and why does a urologist need to know about this? J Pediatr Urol. 2019;15(1):5-11. https://doi.org/10.1016/j.jpurol.2018.10.015
Denburg A, Wilson MG, Johnson Si, Kutluk T, Torode J, Gupta S. Advancing the development of national childhood cancer care strategies in Latin America. Journal of Cancer Policy. 2017;12:7-15.
Guzman CP, Cordoba MA, Godoy N, Castaño A, Ribeiro KB, Moreno F, et al. Childhood cancer in Latin America: from detection to palliative care and survivorship. Cancer Epidemiol. 2020:101837. https://doi.org/10.1016/j.canep.2020.101837
Rokitka DA, Curtin C, Heffler JE, Zevon MA, Attwood K, Mahoney MC. Patterns of Loss to Follow-Up Care Among Childhood Cancer Survivors. Journal of adolescent and young adult oncology. 2017;6(1):67-73. https://doi.org/10.1089/jayao.2016.0023
American Society of Clinical Oncology. Challenges to implementing a survivorship program [Available from: https://www.asco.org/practice-policy/cancer-care-initiatives/preventionsurvivorship/survivorship/survivorship-4.
Silver JK. Strategies to Overcome Cancer Survivorship Care Barriers. PM&R. 2011;3(6):503-6. https://doi.org/10.1016/j.pmrj.2011.04.014
St.Jude Children’s Research Hospital. Cancer Survivorship Fellowship 2020 [Available from: https://www.stjude.org/education-training/advanced-training/clinical-fellows/cancersurvivorship-fellowship.html.
Ministerio de Salud y de Protección Social, Instituto Nacional de Cancerología. Plan Decenal para el Control del Cáncer en Colombia, 2012 – 2021. Bogotá2012.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista Colombiana de Cancerología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Todos los derechos reservados.
